Merck says experimental RSV treatment protected infants in trialBy FinMar NewsOctober 18, 2024The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.Andrew Kelly | ReutersMerck on Thursday said its…
FDA approves Merck pneumococcal disease vaccine designed for adultsBy FinMar NewsJune 17, 2024Zoom In IconArrows pointing outwardsMerck’s new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck’s new vaccine designed to protect adults from a…
